Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

11

Revenue 2017

AstraZeneca

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.

Astra Zeneca

AstraZeneca to present new oncology data at AACR

AstraZeneca to present new oncology data at AACR AstraZeneca (AZ) will present new data highlighting the capabilities of its early oncology portfolio at the American Association for Cancer Research (AACR) Annual Meeting in New Orleans, which is taking place

CHMP recommends marketing authorisation for AZ’s Evusheld in the EU

CHMP recommends marketing authorisation for AZ’s Evusheld in the EU AstraZeneca’s Evusheld, a long-acting antibody combination, has received a recommendation for marketing authorisation in the European Union (EU). ... Mene Pangalos, executive vice president, BioPharmaceuticals R&D, AstraZeneca, said: “Evusheld has

CBI launches new Health Council as part of its Seize The Moment 2030 vision

CBI launches new Health Council as part of its Seize The Moment 2030 vision The inaugural CBI Health Council includes representatives from a number of companies and universities, including: AstraZeneca, Bayer, B-Secur, Bupa, Danone UK&I, Elekta, GE Healthcare, HCA Healthcare, The Health Foundation,

AstraZeneca’s Alexion agrees on $775m settlement with Chugai for Ultomiris

AstraZeneca’s Alexion agrees on $775m settlement with Chugai for Ultomiris AstraZeneca’s (AZ) rare disease group subsiduary Alexion has reached a settlement agreement with Chugai Pharmaceutical Co (Chugai). ... Commenting on the agreed settlement, AstraZeneca said the agreement would be recorded as a non-core charge in its

MHRA grants approval for AstraZeneca’s Evusheld in the UK

MHRA grants approval for AstraZeneca’s Evusheld in the UK AstraZeneca (AZ) has announced that its antibody combination treatment Evusheld (tixagevimab co-packaged with cilgavimab) has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA). ... Tom Keith Roach, president of AstraZeneca

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
VISFO

A team of strategic decision specialists with over 30+ years in the pharma space, we give you confidence through experience....

Latest intelligence

Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
Serious about sustainability?
Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...